Selectable bicistronic vectors in skin gene therapy

Archives of Dermatological Research

Volumn 300, Issue 8, 2008, Pages 415-423

  Scheidemann, Frank ^a   Therrien, Jean Philippe ^b   Pfützner, Wolfgang ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Bicistronic retroviral vector; Fibroblast; Gene therapy; Keratinocyte

Indexed keywords

BICISTRONIC RETROVIRAL VECTOR; COLCHICINE; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MDR GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN;

CELLS, CULTURED; COLCHICINE; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; KERATINOCYTES; SKIN DISEASES; TRANSDUCTION, GENETIC;

EID: 50649119687     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0878-6     Document Type: Article

References (24)

1. R Christensen F Güttler TG Jensen 2002 Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuria Mol Genet Metab 76 313 318
2. R Christensen UB Jensen TG Jensen 2001 Cutaneous gene therapy-an update Histochem Cell Biol 115 73 82
3. V Douin S Bornes Rochaix P LCreancier G Favre AC Prats 2004 Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors BMC Biotechnol 4 16
4. FP Dupuy E Mouly M Mesel-Lemoine C Morel J Abriol M Cherai 2005 Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters J Gene Med 7 1158 1171
5. M Emerman HH Temin 1984 Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism Cell 39 459 467
6. IR Ghattas JR Sanes JE Majors 1991 The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos Mol Cell Biol 11 5848 5859
7. Gottesman MM, Licht T, Zhou Y, Lee C, Shoeshani-Kupitz T, Hafkemeyer P, Hrycyna CR, Pastan I (2000) Selectable markers for gene therapy. In: Templeton N, Lasic D (eds) Gene therapy: therapeutic mechanisms and strategies. Dekker, New York, pp 333-352
8. UR Hengge 2005 Progress and prospects of skin gene therapy: a ten year history Clin Dermatol 23 107 114
9. M Hennecke M Kwissa 2001 Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs Nucleic Acids Res 29 3327 3334
10. CF Higgins 1993 The multidrug resistance P-glycoprotein Curr Opin Cell Biol 5 684 687
11. LM Houdebine J Attal 1999 Internal ribosome entry sites (IRESs): reality and use Transgenic Res 8 157 177
12. Kane SE (1991) High-level expression of foreign genes in mammalian cells. In: Setlow JK (ed) Genetic engineering: principles and methods. Plenum Press, New York, pp 167-182
13. U Kühn A Terunuma W Pfützner RA Foster JC Vogel 2002 In vivo assessment of gene delivery to keratinocytes by lentiviral vectors J Virol 76 1496 1504
14. E Martinez-Salas 1999 Internal ribosome entry site biology and its use in expression vectors Curr Opin Biotechnol 10 458 464
15. MZ Metz A Pichler K Kuchler SE Kane 1998 Construction and characterization of single-transcript tricistronic retroviral vectors using two internal ribosome entry sites Somat Cell Mol Genet 24 53 69
16. H Mizuguchi Z Xu 2000 IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector Mol Ther 1 376 382
17. I Pastan MM Gottesman K Ueda E Lovelace AV Rutherford MC Willingham 1988 A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells Proc Natl Acad Sci USA 85 4486 4490
18. W Pfützner UR Hengge MA Joari RA Foster JC Vogel 1999 Selection of keratinocytes transduced with the multidrug resistance gene in an in vitro skin model presents a strategy for enhancing gene expression in vivo Hum Gene Ther 10 2811 2821
19. W Pfützner A Terunuma CL Tock EK Snead TM Kolodka MM Gottesman L Taichman JC Vogel 2002 Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo Proc Natl Acad Sci USA 199 13096 13101
20. W Pfützner JC Vogel 2000 Advances in skin gene therapy Expert Opin Investig Drugs 9 2069 2083
21. F Scheidemann M Loeser A Kromminga JP Therrien JC Vogel W Pfutzner 2008 The skin as a biofactory for secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts Exp Dermatol 17 481 488
22. DF Spandau M Marques M Bierhuizen G Wagemaker S Huewitz Y Pei R Breese JB Travers 2000 Use of enhanced green fluorescent protein to monitor retroviral-mediated gene therapy in human keratinocytes Exp Dermatol 9 252 257
23. Y Sugimoto I Aksentijevich MM Gottesman I Pastan 1994 Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site Biotechnology 12 694 698
24. CL Thomas AJ Maule 2000 Limitations on the use of fused green fluorescent protein to investigate structure-function relationships for the cauliflower mosaic virus movement protein J Gen Virol 81 1851 1855